GapDB find and trade gaps by statistics
Biotech IBB+XBI 1Y Gap Scan
Updated 2021-09-25
click to sort
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | CLDX | 5 | 4 | 1 | 20.0 |
| Protagonist Therapeutics Inc | PTGX | 3 | 3 | 0 | 0.0 |
| Scholar Rock Holding Corp | SRRK | 1 | 0 | 1 | 100.0 |
| Fulcrum Therapeutics Inc | FULC | 2 | 1 | 1 | 50.0 |
| Crinetics Pharmaceuticals Inc | CRNX | 3 | 2 | 1 | 33.3 |
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | 8 | 5 | 3 | 37.5 |
| Catalyst Pharmaceuticals Inc | CPRX | 3 | 3 | 0 | 0.0 |
| Beam Therapeutics Inc | BEAM | 6 | 4 | 2 | 33.3 |
| Opko Health Inc | OPK | 4 | 4 | 0 | 0.0 |
| Sutro Biopharma Inc | STRO | 5 | 4 | 1 | 20.0 |
| Krystal Biotech Inc | KRYS | 1 | 0 | 1 | 100.0 |
| Guardant Health Inc | GH | 6 | 5 | 1 | 16.7 |
| Nektar Therapeutics | NKTR | 5 | 4 | 1 | 20.0 |
| Theravance Biopharma Inc | TBPH | 2 | 2 | 0 | 0.0 |
| Anika Therapeutics Inc. | ANIK | 6 | 6 | 0 | 0.0 |
| Aeglea BioTherapeutics Inc | AGLE | 5 | 5 | 0 | 0.0 |
| Applied Molecular Transport Inc | AMTI | 2 | 2 | 0 | 0.0 |
| Replimune Group Inc | REPL | 1 | 1 | 0 | 0.0 |
| Fluidigm Corp | FLDM | 4 | 4 | 0 | 0.0 |
| Xencor Inc | XNCR | 1 | 1 | 0 | 0.0 |
| FibroGen Inc | FGEN | 3 | 3 | 0 | 0.0 |
| Intellia Therapeutics Inc | NTLA | 5 | 4 | 1 | 20.0 |
| Exact Sciences Corp. | EXAS | 4 | 3 | 1 | 25.0 |
| Cymabay Therapeutics Inc | CBAY | 2 | 2 | 0 | 0.0 |
| Argen X SE - ADR | ARGX | 22 | 21 | 1 | 4.5 |
| Prothena Corporation plc | PRTA | 6 | 2 | 4 | 66.7 |
| Arvinas Inc | ARVN | 8 | 6 | 2 | 25.0 |
| Amyris Inc | AMRS | 5 | 4 | 1 | 20.0 |
| Applied Therapeutics Inc | APLT | 2 | 2 | 0 | 0.0 |
| uniQure N.V. | QURE | 7 | 6 | 1 | 14.3 |
| Cellectis - ADR | CLLS | 16 | 16 | 0 | 0.0 |
| Madrigal Pharmaceuticals Inc | MDGL | 3 | 3 | 0 | 0.0 |
| Zai Lab Limited - ADR | ZLAB | 17 | 16 | 1 | 5.9 |
| Moderna Inc | MRNA | 12 | 10 | 2 | 16.7 |
| Jounce Therapeutics Inc | JNCE | 1 | 0 | 1 | 100.0 |
| BridgeBio Pharma Inc | BBIO | 2 | 2 | 0 | 0.0 |
| Keros Therapeutics Inc | KROS | 1 | 1 | 0 | 0.0 |
| Berkeley Lights Inc | BLI | 0 | 0 | 0 | 0.0 |
| RAPT Therapeutics Inc | RAPT | 4 | 3 | 1 | 25.0 |
| Voyager Therapeutics Inc | VYGR | 1 | 1 | 0 | 0.0 |
| Axsome Therapeutics Inc | AXSM | 2 | 1 | 1 | 50.0 |
| AnaptysBio Inc | ANAB | 5 | 5 | 0 | 0.0 |
| C4 Therapeutics Inc | CCCC | 0 | 0 | 0 | 0.0 |
| Sangamo Therapeutics Inc | SGMO | 3 | 3 | 0 | 0.0 |
| Syndax Pharmaceuticals Inc | SNDX | 1 | 1 | 0 | 0.0 |
| AlloVir Inc | ALVR | 0 | 0 | 0 | 0.0 |
| Halozyme Therapeutics Inc. | HALO | 5 | 3 | 2 | 40.0 |
| Generation Bio Co | GBIO | 1 | 1 | 0 | 0.0 |
| Kura Oncology Inc | KURA | 3 | 2 | 1 | 33.3 |
| Coherus Biosciences Inc | CHRS | 4 | 3 | 1 | 25.0 |
| Avid Bioservices Inc | CDMO | 2 | 0 | 2 | 100.0 |
| Immunovant Inc | IMVT | 3 | 3 | 0 | 0.0 |
| Marinus Pharmaceuticals Inc | MRNS | 2 | 2 | 0 | 0.0 |
| Tcr2 Therapeutics Inc | TCRR | 3 | 3 | 0 | 0.0 |
| Arcturus Therapeutics Holdings Inc | ARCT | 6 | 3 | 3 | 50.0 |
| Biocryst Pharmaceuticals Inc. | BCRX | 6 | 3 | 3 | 50.0 |
| Macrogenics Inc | MGNX | 2 | 2 | 0 | 0.0 |
| Fulgent Genetics Inc | FLGT | 4 | 4 | 0 | 0.0 |
| G1 Therapeutics Inc | GTHX | 7 | 7 | 0 | 0.0 |
| Iovance Biotherapeutics Inc | IOVA | 6 | 6 | 0 | 0.0 |
| Sarepta Therapeutics Inc | SRPT | 5 | 4 | 1 | 20.0 |
| Compugen Ltd | CGEN | 4 | 4 | 0 | 0.0 |
| Sage Therapeutics Inc | SAGE | 4 | 4 | 0 | 0.0 |
| Wave Life Sciences Ltd. | WVE | 0 | 0 | 0 | 0.0 |
| NuCana plc - ADR | NCNA | 3 | 3 | 0 | 0.0 |
| Akero Therapeutics Inc | AKRO | 0 | 0 | 0 | 0.0 |
| Ziopharm Oncology, Inc. | ZIOP | 2 | 2 | 0 | 0.0 |
| Black Diamond Therapeutics Inc | BDTX | 2 | 2 | 0 | 0.0 |
| Verona Pharma Plc - ADR | VRNA | 6 | 6 | 0 | 0.0 |
| Nkarta Inc | NKTX | 0 | 0 | 0 | 0.0 |
| Sana Biotechnology Inc | SANA | 1 | 1 | 0 | 0.0 |
| Neurocrine Biosciences, Inc. | NBIX | 1 | 1 | 0 | 0.0 |
| Biogen Inc | BIIB | 5 | 4 | 1 | 20.0 |
| Zentalis Pharmaceuticals Inc | ZNTL | 2 | 1 | 1 | 50.0 |
| Vertex Pharmaceuticals, Inc. | VRTX | 4 | 4 | 0 | 0.0 |
| Seres Therapeutics Inc | MCRB | 1 | 1 | 0 | 0.0 |
| CytomX Therapeutics Inc | CTMX | 3 | 2 | 1 | 33.3 |
| Viking Therapeutics Inc | VKTX | 3 | 2 | 1 | 33.3 |
| Zymeworks Inc | ZYME | 2 | 2 | 0 | 0.0 |
| Morphic Holding Inc | MORF | 4 | 3 | 1 | 25.0 |
| Bio-Techne Corp | TECH | 10 | 7 | 3 | 30.0 |
| Agios Pharmaceuticals Inc | AGIO | 3 | 2 | 1 | 33.3 |
| Deciphera Pharmaceuticals Inc | DCPH | 2 | 2 | 0 | 0.0 |
| VBI Vaccines Inc. | VBIV | 1 | 1 | 0 | 0.0 |
| BioXcel Therapeutics Inc | BTAI | 3 | 3 | 0 | 0.0 |
| Mesoblast Ltd - ADR | MESO | 23 | 22 | 1 | 4.3 |
| Rocket Pharmaceuticals Inc | RCKT | 4 | 4 | 0 | 0.0 |
| Eagle Pharmaceuticals Inc | EGRX | 5 | 3 | 2 | 40.0 |
| Myriad Genetics, Inc. | MYGN | 3 | 2 | 1 | 33.3 |
| Pacific Biosciences of California Inc | PACB | 6 | 5 | 1 | 16.7 |
| Flexion Therapeutics Inc | FLXN | 2 | 2 | 0 | 0.0 |
| Repare Therapeutics Inc | RPTX | 2 | 2 | 0 | 0.0 |
| BioAtla Inc | BCAB | 2 | 2 | 0 | 0.0 |
| MeiraGTx Holdings plc | MGTX | 1 | 1 | 0 | 0.0 |
| Aprea Therapeutics Inc | APRE | 2 | 2 | 0 | 0.0 |
| Editas Medicine Inc | EDIT | 6 | 5 | 1 | 16.7 |
| Provention Bio Inc | PRVB | 3 | 3 | 0 | 0.0 |
| Gossamer Bio Inc | GOSS | 2 | 1 | 1 | 50.0 |
| Altimmune Inc | ALT | 3 | 3 | 0 | 0.0 |
| Myovant Sciences Ltd | MYOV | 4 | 4 | 0 | 0.0 |
| Grifols SA - ADR - Level III | GRFS | 14 | 13 | 1 | 7.1 |
| Epizyme Inc | EPZM | 1 | 1 | 0 | 0.0 |
| Stoke Therapeutics Inc | STOK | 2 | 2 | 0 | 0.0 |
| AVITA Medical Inc | RCEL | 16 | 15 | 1 | 6.2 |
| NovoCure Ltd | NVCR | 8 | 7 | 1 | 12.5 |
| Karuna Therapeutics Inc | KRTX | 2 | 1 | 1 | 50.0 |
| Aldeyra Therapeutics Inc | ALDX | 6 | 5 | 1 | 16.7 |
| Intercept Pharmaceuticals Inc | ICPT | 4 | 4 | 0 | 0.0 |
| Kymera Therapeutics Inc | KYMR | 5 | 4 | 1 | 20.0 |
| Allogene Therapeutics Inc | ALLO | 3 | 3 | 0 | 0.0 |
| Poseida Therapeutics Inc | PSTX | 2 | 2 | 0 | 0.0 |
| Regenxbio Inc | RGNX | 7 | 6 | 1 | 14.3 |
| Adc Therapeutics SA | ADCT | 1 | 1 | 0 | 0.0 |
| ITeos Therapeutics Inc | ITOS | 2 | 0 | 2 | 100.0 |
| Cogent Biosciences Inc | COGT | 1 | 1 | 0 | 0.0 |
| Atara Biotherapeutics Inc | ATRA | 2 | 2 | 0 | 0.0 |
| Selecta Biosciences Inc | SELB | 8 | 7 | 1 | 12.5 |
| Ngm Biopharmaceuticals Inc | NGM | 2 | 2 | 0 | 0.0 |
| Inovio Pharmaceuticals Inc | INO | 4 | 4 | 0 | 0.0 |
| PMV Pharmaceuticals Inc | PMVP | 0 | 0 | 0 | 0.0 |
| Alkermes plc | ALKS | 5 | 2 | 3 | 60.0 |
| AC Immune SA | ACIU | 6 | 6 | 0 | 0.0 |
| Cortexyme Inc | CRTX | 1 | 1 | 0 | 0.0 |
| Esperion Therapeutics Inc. | ESPR | 1 | 1 | 0 | 0.0 |
| Arcus Biosciences Inc | RCUS | 2 | 1 | 1 | 50.0 |
| Arena Pharmaceuticals Inc | ARNA | 3 | 3 | 0 | 0.0 |
| Nextcure Inc | NXTC | 1 | 1 | 0 | 0.0 |
| Cerevel Therapeutics Holdings Inc | CERE | 4 | 1 | 3 | 75.0 |
| Ionis Pharmaceuticals Inc | IONS | 5 | 5 | 0 | 0.0 |
| Allakos Inc | ALLK | 3 | 2 | 1 | 33.3 |
| Spero Therapeutics Inc | SPRO | 6 | 5 | 1 | 16.7 |
| Chinook Therapeutics Inc | KDNY | 5 | 5 | 0 | 0.0 |
| IGM Biosciences Inc | IGMS | 1 | 1 | 0 | 0.0 |
| PTC Therapeutics Inc | PTCT | 2 | 2 | 0 | 0.0 |
| Cara Therapeutics Inc | CARA | 5 | 4 | 1 | 20.0 |
| Alector Inc | ALEC | 8 | 5 | 3 | 37.5 |
| Galapagos NV - ADR | GLPG | 33 | 33 | 0 | 0.0 |
| Tricida Inc | TCDA | 4 | 4 | 0 | 0.0 |
| Kodiak Sciences Inc | KOD | 4 | 3 | 1 | 25.0 |
| Alnylam Pharmaceuticals Inc | ALNY | 3 | 3 | 0 | 0.0 |
| Geron Corp. | GERN | 4 | 4 | 0 | 0.0 |
| Kezar Life Sciences Inc | KZR | 0 | 0 | 0 | 0.0 |
| Kaleido Biosciences Inc | KLDO | 2 | 2 | 0 | 0.0 |
| Pliant Therapeutics Inc | PLRX | 1 | 1 | 0 | 0.0 |
| Frequency Therapeutics Inc | FREQ | 1 | 1 | 0 | 0.0 |
| Ardelyx Inc | ARDX | 5 | 5 | 0 | 0.0 |
| Reata Pharmaceuticals Inc - Class A | RETA | 8 | 7 | 1 | 12.5 |
| Adaptive Biotechnologies Corp | ADPT | 6 | 6 | 0 | 0.0 |
| Nanostring Technologies Inc | NSTG | 6 | 6 | 0 | 0.0 |
| Arrowhead Pharmaceuticals Inc. | ARWR | 3 | 3 | 0 | 0.0 |
| AMGEN Inc. | AMGN | 5 | 5 | 0 | 0.0 |
| Caredx Inc | CDNA | 6 | 5 | 1 | 16.7 |
| Waters Corp. | WAT | 10 | 7 | 3 | 30.0 |
| Personalis Inc | PSNL | 2 | 2 | 0 | 0.0 |
| Concert Pharmaceuticals Inc | CNCE | 2 | 2 | 0 | 0.0 |
| Dynavax Technologies Corp. | DVAX | 9 | 5 | 4 | 44.4 |
| Orchard Therapeutics plc - ADR | ORTX | 4 | 4 | 0 | 0.0 |
| XBiotech Inc | XBIT | 2 | 1 | 1 | 50.0 |
| Anavex Life Sciences Corporation | AVXL | 7 | 5 | 2 | 28.6 |
| Annexon Inc | ANNX | 1 | 1 | 0 | 0.0 |
| Recursion Pharmaceuticals Inc - Class A | RXRX | 2 | 1 | 1 | 50.0 |
| Syros Pharmaceuticals Inc. | SYRS | 3 | 3 | 0 | 0.0 |
| Mersana Therapeutics Inc | MRSN | 3 | 3 | 0 | 0.0 |
| Clovis Oncology Inc | CLVS | 5 | 4 | 1 | 20.0 |
| Precision Biosciences Inc | DTIL | 6 | 6 | 0 | 0.0 |
| Mannkind Corp | MNKD | 5 | 4 | 1 | 20.0 |
| Charles River Laboratories International Inc. | CRL | 10 | 4 | 6 | 60.0 |
| Insmed Inc | INSM | 4 | 3 | 1 | 25.0 |
| Athenex Inc | ATNX | 2 | 2 | 0 | 0.0 |
| DermTech Inc | DMTK | 7 | 5 | 2 | 28.6 |
| Ascendis Pharma A/S - ADR | ASND | 3 | 2 | 1 | 33.3 |
| Kala Pharmaceuticals Inc | KALA | 3 | 3 | 0 | 0.0 |
| Dicerna Pharmaceuticals Inc | DRNA | 3 | 3 | 0 | 0.0 |
| Mirati Therapeutics Inc | MRTX | 3 | 3 | 0 | 0.0 |
| IVERIC bio Inc | ISEE | 5 | 4 | 1 | 20.0 |
| Unity Biotechnology Inc | UBX | 5 | 5 | 0 | 0.0 |
| Regeneron Pharmaceuticals, Inc. | REGN | 8 | 7 | 1 | 12.5 |
| Cerus Corp. | CERS | 5 | 4 | 1 | 20.0 |
| Mimedx Group Inc | MDXG | 1 | 1 | 0 | 0.0 |
| Avidity Biosciences Inc | RNA | 4 | 3 | 1 | 25.0 |
| IQVIA Holdings Inc | IQV | 10 | 8 | 2 | 20.0 |
| Relmada Therapeutics Inc | RLMD | 0 | 0 | 0 | 0.0 |
| Nurix Therapeutics Inc | NRIX | 1 | 1 | 0 | 0.0 |
| Larimar Therapeutics Inc | LRMR | 4 | 4 | 0 | 0.0 |
| KalVista Pharmaceuticals Inc | KALV | 1 | 0 | 1 | 100.0 |
| Apellis Pharmaceuticals Inc | APLS | 5 | 5 | 0 | 0.0 |
| Cue Biopharma Inc | CUE | 4 | 4 | 0 | 0.0 |
| Vir Biotechnology Inc | VIR | 4 | 4 | 0 | 0.0 |
| Meridian Bioscience Inc. | VIVO | 5 | 5 | 0 | 0.0 |
| Turning Point Therapeutics Inc | TPTX | 3 | 2 | 1 | 33.3 |
| Chimerix Inc | CMRX | 4 | 2 | 2 | 50.0 |
| Arbutus Biopharma Corp | ABUS | 4 | 2 | 2 | 50.0 |
| Ovid Therapeutics Inc | OVID | 1 | 0 | 1 | 100.0 |
| Cabaletta Bio Inc | CABA | 2 | 2 | 0 | 0.0 |
| Karyopharm Therapeutics Inc | KPTI | 4 | 4 | 0 | 0.0 |
| Humanigen Inc | HGEN | 6 | 6 | 0 | 0.0 |
| Adverum Biotechnologies Inc | ADVM | 3 | 3 | 0 | 0.0 |
| Fate Therapeutics Inc | FATE | 7 | 6 | 1 | 14.3 |
| Horizon Therapeutics Plc | HZNP | 8 | 6 | 2 | 25.0 |
| 10x Genomics Inc - Class A | TXG | 7 | 7 | 0 | 0.0 |
| Harpoon Therapeutics Inc | HARP | 2 | 2 | 0 | 0.0 |
| Veracyte Inc | VCYT | 7 | 7 | 0 | 0.0 |
| Atreca Inc - Class A | BCEL | 3 | 3 | 0 | 0.0 |
| Novavax, Inc. | NVAX | 10 | 9 | 1 | 10.0 |
| Emergent Biosolutions Inc | EBS | 8 | 8 | 0 | 0.0 |
| Ultragenyx Pharmaceutical Inc. | RARE | 5 | 4 | 1 | 20.0 |
| Ironwood Pharmaceuticals Inc - Class A | IRWD | 3 | 0 | 3 | 100.0 |
| Agenus Inc | AGEN | 4 | 2 | 2 | 50.0 |
| Rubius Therapeutics Inc | RUBY | 6 | 5 | 1 | 16.7 |
| Lineage Cell Therapeutics Inc | LCTX | 6 | 6 | 0 | 0.0 |
| Blueprint Medicines Corp | BPMC | 3 | 3 | 0 | 0.0 |
| Tiziana Life Sciences Plc - ADR | TLSA | 8 | 8 | 0 | 0.0 |
| Kiniksa Pharmaceuticals Ltd - Class A | KNSA | 3 | 3 | 0 | 0.0 |
| Affimed N.V. | AFMD | 6 | 5 | 1 | 16.7 |
| Revance Therapeutics Inc | RVNC | 1 | 1 | 0 | 0.0 |
| Surface Oncology Inc | SURF | 7 | 5 | 2 | 28.6 |
| Amicus Therapeutics Inc | FOLD | 3 | 3 | 0 | 0.0 |
| Mettler-Toledo International, Inc. | MTD | 10 | 8 | 2 | 20.0 |
| Legend Biotech Corp - ADR | LEGN | 2 | 2 | 0 | 0.0 |
| Cytokinetics Inc | CYTK | 6 | 4 | 2 | 33.3 |
| United Therapeutics Corp | UTHR | 4 | 1 | 3 | 75.0 |
| ImmunityBio Inc | IBRX | 5 | 5 | 0 | 0.0 |
| Gamida Cell Ltd | GMDA | 4 | 4 | 0 | 0.0 |
| Codexis Inc. | CDXS | 7 | 5 | 2 | 28.6 |
| TG Therapeutics Inc | TGTX | 7 | 6 | 1 | 14.3 |
| Rigel Pharmaceuticals | RIGL | 4 | 4 | 0 | 0.0 |
| Bluebird bio Inc | BLUE | 6 | 6 | 0 | 0.0 |
| Travere Therapeutics Inc | TVTX | 4 | 3 | 1 | 25.0 |
| Prelude Therapeutics Inc | PRLD | 2 | 2 | 0 | 0.0 |
| Illumina Inc | ILMN | 8 | 5 | 3 | 37.5 |
| Ideaya Biosciences Inc | IDYA | 4 | 4 | 0 | 0.0 |
| Odonate Therapeutics Inc | ODT | 3 | 3 | 0 | 0.0 |
| Magenta Therapeutics Inc | MGTA | 3 | 2 | 1 | 33.3 |
| Immunic Inc | IMUX | 3 | 3 | 0 | 0.0 |
| Invitae Corp | NVTA | 11 | 10 | 1 | 9.1 |
| Cel-Sci Corp. | CVM | 4 | 4 | 0 | 0.0 |
| Gilead Sciences, Inc. | GILD | 6 | 5 | 1 | 16.7 |
| Neoleukin Therapeutics Inc | NLTX | 3 | 2 | 1 | 33.3 |
| AvroBio Inc | AVRO | 5 | 5 | 0 | 0.0 |
| Albireo Pharma Inc | ALBO | 5 | 5 | 0 | 0.0 |
| Medicinova Inc | MNOV | 2 | 2 | 0 | 0.0 |
| Assembly Biosciences Inc | ASMB | 3 | 3 | 0 | 0.0 |
| Repligen Corp. | RGEN | 11 | 9 | 2 | 18.2 |
| Natera Inc | NTRA | 7 | 5 | 2 | 28.6 |
| Sorrento Therapeutics Inc | SRNE | 7 | 6 | 1 | 14.3 |
| Quanterix Corp | QTRX | 7 | 5 | 2 | 28.6 |
| Exelixis Inc | EXEL | 5 | 4 | 1 | 20.0 |
| Supernus Pharmaceuticals Inc | SUPN | 6 | 4 | 2 | 33.3 |
| Inozyme Pharma Inc | INZY | 0 | 0 | 0 | 0.0 |
| Vericel Corp | VCEL | 5 | 2 | 3 | 60.0 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 1 | 1 | 0 | 0.0 |
| Radius Health Inc. | RDUS | 3 | 3 | 0 | 0.0 |
| Revolution Medicines Inc | RVMD | 3 | 3 | 0 | 0.0 |
| Ligand Pharmaceuticals, Inc. - Class B | LGND | 3 | 2 | 1 | 33.3 |
| Morphosys AG - ADR | MOR | 36 | 36 | 0 | 0.0 |
| Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 7 | 7 | 0 | 0.0 |
| Castle Biosciences Inc | CSTL | 3 | 2 | 1 | 33.3 |
| I-Mab - ADR | IMAB | 5 | 5 | 0 | 0.0 |
| ORIC Pharmaceuticals Inc | ORIC | 1 | 0 | 1 | 100.0 |
| Relay Therapeutics Inc | RLAY | 1 | 1 | 0 | 0.0 |
| CRISPR Therapeutics AG | CRSP | 8 | 7 | 1 | 12.5 |
| Vanda Pharmaceuticals Inc | VNDA | 3 | 2 | 1 | 33.3 |
| Global Blood Therapeutics Inc. | GBT | 3 | 3 | 0 | 0.0 |
| Verastem Inc | VSTM | 3 | 2 | 1 | 33.3 |
| Immunogen, Inc. | IMGN | 5 | 4 | 1 | 20.0 |
| Kadmon Holdings Inc | KDMN | 4 | 3 | 1 | 25.0 |
| Acadia Pharmaceuticals Inc | ACAD | 2 | 2 | 0 | 0.0 |
| ChemoCentryx Inc | CCXI | 2 | 1 | 1 | 50.0 |
| Bruker Corp | BRKR | 5 | 4 | 1 | 20.0 |
| Heron Therapeutics Inc | HRTX | 1 | 1 | 0 | 0.0 |
| Adaptimmune Therapeutics Plc - ADR | ADAP | 2 | 1 | 1 | 50.0 |
| Rhythm Pharmaceuticals Inc. | RYTM | 3 | 3 | 0 | 0.0 |
| Puma Biotechnology Inc | PBYI | 1 | 1 | 0 | 0.0 |
| Forma Therapeutics Holdings Inc | FMTX | 0 | 0 | 0 | 0.0 |
| Vaxcyte Inc | PCVX | 3 | 3 | 0 | 0.0 |
| Enanta Pharmaceuticals Inc | ENTA | 4 | 3 | 1 | 25.0 |
| Intra-Cellular Therapies Inc | ITCI | 2 | 2 | 0 | 0.0 |
| Abbvie Inc | ABBV | 7 | 4 | 3 | 42.9 |
| Redhill Biopharma - ADR | RDHL | 5 | 5 | 0 | 0.0 |
| Alx Oncology Holdings Inc | ALXO | 4 | 3 | 1 | 25.0 |
| UroGen Pharma Ltd | URGN | 2 | 2 | 0 | 0.0 |
| Incyte Corp. | INCY | 5 | 5 | 0 | 0.0 |
| Medpace Holdings Inc | MEDP | 7 | 5 | 2 | 28.6 |
| Organogenesis Holdings Inc - Class A | ORGO | 7 | 6 | 1 | 14.3 |
| Denali Therapeutics Inc | DNLI | 3 | 3 | 0 | 0.0 |
| Genmab - ADR | GMAB | 37 | 28 | 9 | 24.3 |
| Seagen Inc | SGEN | 8 | 8 | 0 | 0.0 |
| SpringWorks Therapeutics Inc | SWTX | 1 | 1 | 0 | 0.0 |
| Omeros Corporation | OMER | 3 | 2 | 1 | 33.3 |
| SIGA Technologies Inc | SIGA | 3 | 3 | 0 | 0.0 |
| Twist Bioscience Corp | TWST | 10 | 8 | 2 | 20.0 |
| Passage Bio Inc | PASG | 2 | 2 | 0 | 0.0 |
| Calithera Biosciences Inc | CALA | 2 | 2 | 0 | 0.0 |
| Vaxart Inc | VXRT | 7 | 7 | 0 | 0.0 |
| BeiGene Ltd - ADR | BGNE | 13 | 10 | 3 | 23.1 |
| Curis Inc | CRIS | 6 | 4 | 2 | 33.3 |
| Acceleron Pharma Inc | XLRN | 4 | 3 | 1 | 25.0 |
| Homology Medicines Inc | FIXX | 4 | 3 | 1 | 25.0 |
| VistaGen Therapeutics Inc | VTGN | 6 | 4 | 2 | 33.3 |
| Akebia Therapeutics Inc. | AKBA | 2 | 2 | 0 | 0.0 |
| BioNTech SE - ADR | BNTX | 26 | 19 | 7 | 26.9 |
| Eiger BioPharmaceuticals Inc | EIGR | 2 | 2 | 0 | 0.0 |
| Xenon Pharmaceuticals Inc | XENE | 1 | 1 | 0 | 0.0 |
| Precigen Inc | PGEN | 5 | 5 | 0 | 0.0 |
| Y-Mabs Therapeutics Inc | YMAB | 2 | 2 | 0 | 0.0 |
| Arcutis Biotherapeutics Inc | ARQT | 5 | 5 | 0 | 0.0 |
| Ocugen Inc | OCGN | 10 | 5 | 5 | 50.0 |
Gap Statistics:
Must-Read Books on Technical Analysis:
Japanese Candlestick Charting Techniques by Steve Nison
Technical Analysis of the Financial Markets by John Murphy
